influenza virus production for cell-based flu vaccines
ContiVir is a research project of the Max Planck Institute in Germany. We have succesfully produced cell-based influenza virus with stable titers in continuous mode. We have also developed a highly efficient purification platform with influenza virus recoveries beyond 98%
We have developed a virus production system based on a continuous tubular bioreactor & a capture chromatography step with virtually full recovery for a wide range of influenza viruses.
These technologies together can be up to ten-fold more efficient than current batch production platforms.
Video of ContiVir technology:
COMPARED TO INFLUENZA BATCH VIRUS PRODUCTION
(20 times smaller equipments)
(save weeks or months)
(reduced manufacturing costs)